Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
Clinical trial NCT01485861 · COMPLETED
Trial details
- NCT number
- NCT01485861
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-11
- Primary completion
- 2015-09-01
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.